Genetic Analysis

Shares of Illumina, Inc. (NASDAQ: ILMN) plunged nearly 20 percent Tuesday morning after the company reported disappointing preliminary first quarter results on Monday. Illumina said it expects to record revenue of $572 million in the first quarter. Even though the company's guidance...